SDZNY:OTCMKTS
SANDOZ GROUP ADR
$84.47
arrow_downward
-3.50%(-3.06) 1D
Sep 4, 1:02:25 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZNY...
Open
$85.20
High
$85.36
Low
$84.42
Mkt. cap
30.08B
Avg. vol.
22.59K
Volume
6.58K
52-wk high
$94.15
52-wk low
$55.42
Shares outstanding
440.00M
No. of employees
20K
Open
$85.20
High
$85.36
Low
$84.42
Mkt. cap
30.08B
Avg. vol.
22.59K
Volume
6.58K
52-wk high
$94.15
52-wk low
$55.42
Shares outstanding
440.00M
No. of employees
20K
News stories
From web sources and news partners
Seeking Alpha
·
39 minutes ago
Sandoz: More Than A Generic Company, But Too Expensive Here (OTCMKTS:SDZNY)
Business Post Nigeria
·
15 hours ago
Alpro Pharmacy, Sandoz Malaysia and Doc2Us Launch ACCESS360 to Make Stroke
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About SANDOZ GROUP ADR